Global consumer organizations

2016 ◽  
Vol 53 (11) ◽  
pp. 53-4887-53-4887
Keyword(s):  
Consumer Organizations

Consumers’ WTP for certified traceable tea in China

2015 ◽  
Vol 117 (5) ◽  
pp. 1440-1452 ◽  
Author(s):  
Xiaolin Liu ◽  
Lingling Xu ◽  
Dian Zhu ◽  
Linhai Wu
Keyword(s):  
Developed Countries ◽  
Price Premium ◽  
Chinese Government ◽  
Payment Card ◽  
Content Type ◽  
Traceability System ◽  
Consumer Organizations ◽  
The Government ◽  
Premium Income ◽  
The Cost

Purpose – The purpose of this paper is to examine consumer attitudes toward and willingness to pay (WTP) for traceability of tea in China. Design/methodology/approach – The authors used the payment card method to elicit WTP for certified traceable tea and logistic regression model to analyze the factors that affected consumers’ WTP. Findings – The results revealed that most consumers in China were concerned over tea safety; however, their WTP for certified traceable tea was limited. Only income and the degree of concern over tea safety affected the consumer’s WTP for certified traceable tea greatly. When it came to consumers’ WTP a positive price premium, income level, education, and attitude toward traceability of tea significantly influenced the actual premium consumers were willing to pay. Practical implications – The Chinese government and tea producers should pay attention when implementing tea traceability system. First, raising the consumers’ income contributes to the premiums that consumers are willing to pay for certified traceable tea. Second, social groups, consumer organizations and tea producers should popularize knowledge of tea traceability. Third, given the low price premiums that consumers are willing to pay, the establishment of viable traceability of tea in China requires the producers and the government to bear some of the cost associated with the implementation of this system. Originality/value – In past studies on WTP for certified traceable food, the study is focussed on meat in developed countries, and the research has expanded range of study, by conducting a survey in China to determine consumers’ WTP for certified traceable tea, and by empirically examining the main factors that influence the willingness of consumers to pay a price premium for certified traceable tea, as well as the premium that these consumers are willing to pay.

Characteristics of Consumer Complainants: Implications for Marketing and Public Policy

1984 ◽  
Vol 3 (1) ◽  
pp. 67-84 ◽  
Author(s):  
Mel S. Moyer
Keyword(s):  
Public Policy ◽  
Government Assistance ◽  
Intelligence Gathering ◽  
Complaint Handling ◽  
Consumer Organizations

Compared to more passive consumers, active complainers are upscale demographically and are more active information seekers. They are not more critical of the marketplace. They are more negative toward government assistance to consumers and more pessimistic about the effectiveness of consumer organizations. These findings mean that if they are to be fully effective, especially when operated by governments and consumer organizations, complaint-handling systems must be augmented by other intelligence-gathering instruments, must be more consumer-oriented, and must be positioned around target clienteles.

scholarly journals Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility

2019 ◽  
Vol 2019 (1) ◽  
Author(s):  
M F Costello ◽  
M L Misso ◽  
A Balen ◽  
J Boyle ◽  
L Devoto ◽  
...  
Keyword(s):  
Conflicts Of Interest ◽  
Guideline Development ◽  
Polycystic Ovary ◽  
Evidence Synthesis ◽  
Evidence Based ◽  
Agree Ii ◽  
Infertile Women ◽  
International Evidence ◽  
Consumer Organizations ◽  
Evidence Based Guideline

Abstract STUDY QUESTION What is the recommended assessment and management of infertile women with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertize and consumer preference? SUMMARY ANSWER International evidence-based guidelines, including 44 recommendations and practice points, addressed prioritized questions to promote consistent, evidence-based care and improve the experience and health outcomes of infertile women with PCOS. WHAT IS KNOWN ALREADY Previous guidelines on PCOS lacked rigorous evidence-based processes, failed to engage consumer and multidisciplinary perspectives or were outdated. The assessment and management of infertile women with PCOS are inconsistent. The needs of women with PCOS are not being adequately met and evidence practice gaps persist. PARTICIPANTS/MATERIALS, SETTING, METHODS Governance included a six continent international advisory and a project board, a multidisciplinary international guideline development group (GDG), consumer and translation committees. Extensive health professional and consumer engagement informed the guideline scope and priorities. The engaged international society-nominated panel included endocrinology, gynaecology, reproductive endocrinology, obstetrics, public health and other experts, alongside consumers, project management, evidence synthesis and translation experts. Thirty-seven societies and organizations covering 71 countries engaged in the process. Extensive online communication and two face-to-face meetings over 15 months addressed 19 prioritized clinical questions involving nine evidence-based reviews and 10 narrative reviews. Evidence-based recommendations (EBRs) were formulated prior to consensus voting within the guideline panel. STUDY DESIGN, SIZE, DURATION International evidence-based guideline development engaged professional societies and consumer organizations with multidisciplinary experts and women with PCOS directly involved at all stages. A (AGREE) II-compliant processes were followed, with extensive evidence synthesis. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied across evidence quality, desirable and undesirable consequences, feasibility, acceptability, cost, implementation and ultimately recommendation strength. The guideline was peer-reviewed by special interest groups across our partner and collaborating societies and consumer organizations, was independently assessed against AGREE II criteria and underwent methodological review. This guideline was approved by all members of the GDG and has been approved by the NHMRC. MAIN RESULTS AND THE ROLE OF CHANCE The quality of evidence (QOE) for the EBRs in the assessment and management of infertility in PCOS included very low (n = 1), low (n = 9) and moderate (n = 4) quality with no EBRs based on high-quality evidence. The guideline provides 14 EBRs, 10 clinical consensus recommendations (CCRs) and 20 clinical practice points on the assessment and management of infertility in PCOS. Key changes in this guideline include emphasizing evidence-based fertility therapy, including cheaper and safer fertility management. LIMITATIONS, REASONS FOR CAUTION Overall evidence is generally of low to moderate quality, requiring significantly greater research in this neglected, yet common condition. Regional health systems vary and a process for adaptation of this guideline is provided. WIDER IMPLICATIONS OF THE FINDINGS The international guideline for the assessment and management of infertility in PCOS provides clinicians with clear advice on best practice based on the best available evidence, expert multidisciplinary input and consumer preferences. Research recommendations have been generated and a comprehensive multifaceted dissemination and translation program supports the guideline with an integrated evaluation program. STUDY FUNDING/COMPETING INTEREST(S) The guideline was primarily funded by the Australian National Health and Medical Research Council of Australia (NHMRC) supported by a partnership with ESHRE and the American Society for Reproductive Medicine (ASRM). GDG members did not receive payment. Travel expenses were covered by the sponsoring organizations. Disclosures of conflicts of interest were declared at the outset and updated throughout the guideline process, aligned with NHMRC guideline processes. Dr Costello has declared shares in Virtus Health and past sponsorship from Merck Serono for conference presentations. Prof. Norman has declared a minor shareholder interest in the IVF unit Fertility SA, travel support from Merck and grants from Ferring. Prof. Norman also has scientific advisory board duties for Ferring. The remaining authors have no conflicts of interest to declare. This article was not externally peer-reviewed by Human Reproduction Open.

COLLECTIVE REDRESS PROCEDURES–EUROPEAN DEBATES

2009 ◽  
Vol 58 (2) ◽  
pp. 379-409 ◽  
Author(s):  
Duncan Fairgrieve ◽  
Geraint Howells
Keyword(s):  
Policy Development ◽  
National Level ◽  
Public Authorities ◽  
Member States ◽  
Collective Redress ◽  
Opt Out ◽  
Consumer Organizations ◽  
Civil Procedures ◽  
The Eu

AbstractCollective redress mechanisms for consumer claims seek both to allow legal systems to accommodate mass litigation without being overwhelmed and to enable litigation to be viable where individual claims would not be economic. The article maps a number of recent reforms and reform proposals relating to consumer collective redress at national level and comments on EU developments. It notes that there is insufficient recognition of the differences between schemes geared at managing mass litigation as opposed to those aimed at facilitating otherwise non-viable claims. There are however signs that a European style of collective redress procedure is developing, which emphasize the role of public authorities and consumer organizations as gatekeepers to collective redress. The EU is unlikely to be able to impose collective redress procedures on national civil procedures, but the EU could prompt Member States to reflect on the need for national reforms. There may be limited scope for an EU mechanism to address the problem of individually non-viable consumer claims. This would however have to address certain fundamental issues such as the opt-out mechanism, cy-près distribution and funding if consumer organizations are to be encouraged to bring such actions. At a legal doctrinal level, it is interesting to note the influence of comparative studies on policy development within Member States as well as at the EU level.

Protest, Social Movements, and Spaces for Politically Oriented Consumerist Actions—Nationally, Transnationally, and Locally

2018 ◽  
pp. 68-88
Author(s):  
Francesca Forno
Keyword(s):  
Social Movements ◽  
Large Scale ◽  
Social Movement Organizations ◽  
Predatory Lending ◽  
Grassroots Organizations ◽  
Political Consumerism ◽  
Consumer Organizations ◽  
Ethical Criteria ◽  
Movement Organizations ◽  
The Relationship

This chapter discusses the relationship between social movements and political consumerism. Besides traditional consumer organizations that seek to protect customers from corporate abuse (such as unsafe products, predatory lending, or false advertising), political consumer practices have become increasingly employed to achieve diverse political and social goals. Calls to citizens to take action in their role as consumers have been made by social movement organizations of various types, either to build up transnational awareness so as to step up pressure on corporations or to facilitate the purchase of goods/services that meet specific ethical criteria. Along with large-scale boycotting and global fair trade initiatives, market-based actions have entered the repertoire of a number of local grassroots organizations seeking bottom-up solutions for sustainable development, within which the act of shopping moves beyond a form of individuals taking responsibility to become a tool for constructing collective, citizenship-driven alternative styles of provisioning.

scholarly journals The Allergen Bureau VITAL Program

2018 ◽  
Vol 101 (1) ◽  
pp. 77-82 ◽  
Author(s):  
Simon Brooke Taylor ◽  
Georgina Christensen ◽  
Kirsten Grinter ◽  
Robin Sherlock ◽  
Lisa Warren
Keyword(s):  
Risk Assessment ◽  
Food Industry ◽  
Assessment Process ◽  
Food Allergens ◽  
Multiple Stakeholders ◽  
Risk Assessment Process ◽  
Scientific Principles ◽  
Consumer Organizations ◽  
Allergen Labelling

Abstract This paper sets out the role of the Allergen Bureau and the Voluntary Incidental Trace Allergen Labelling (VITAL) Program from its origin in 2007 to its current iteration, VITAL 2. Herewith are outlined the scientific principles that support the program; the program’s application in the food chain; and the benefits of the program’s use to the food industry, clinicians, and the allergic consumer. VITAL was developed by the Australian and New Zealand food industry in consultation with multiple stakeholders, including consumer organizations, industry bodies, regulators, and retailers, to provide a standardized, science-based risk assessment process for the investigation of the potential presence of food allergens due to cross-contact and to determine whether, for cases in which the allergen is unable to be removed or controlled consistently, precautionary statements are required. The aim of the program is to provide a consistent process, a standardized approach, and a relevant cross-contact statement to allow the allergic consumer to make an informed decision regarding consumption of food.

Sign in / Sign up

Export Citation Format

Share Document